Constantinou, MP;
Goodyer, IM;
Eisler, I;
Butler, S;
Kraam, A;
Scott, S;
Pilling, S;
... Fonagy, P; + view all
(2019)
Changes in General and Specific Psychopathology Factors Over a Psychosocial Intervention.
Journal of the American Academy of Child & Adolescent Psychiatry
, 58
(8)
pp. 776-786.
10.1016/j.jaac.2018.11.011.
Preview |
Text
Butler_Article.pdf - Accepted Version Download (392kB) | Preview |
Preview |
Text
Butler_Supplementary Materials & Tables.pdf - Accepted Version Download (346kB) | Preview |
![]() |
Image
Butler_Figures.zip - Accepted Version Download (2MB) |
Abstract
OBJECTIVE: Recent research suggests that comorbidity among child and adolescent psychiatric symptoms can be explained by a single general psychopathology ('p') factor, as well as more specific factors summarizing clusters of symptoms. We investigated within- and between-person changes in the general and specific psychopathology factors over a psychosocial intervention. METHOD: We ran a secondary analysis of the Systemic Therapy for At-Risk Teens study, a pragmatic randomized controlled trial that compared the effects of multisystemic therapy to management-as-usual for reducing antisocial behavior in 684 adolescents (82% male; 11-18 at baseline) over an 18-month period. The general p factor, as well as specific antisocial, attention, anxiety, and mood factors, were estimated from a symptom-level analysis of a set of narrow-band symptom scales measured repeatedly over the study. General and specific psychopathology factors were assessed for reliability, validity, and within- and between-person change using a parallel process multilevel growth model. RESULTS: A revised bifactor model that included a general p factor and specific anxiety, mood, antisocial, and attention factors with cross-loadings fit the data best. While the factor structure was multidimensional, p accounted for most of the variance in total scores. The p, anxiety, and antisocial factors predicted within-person variation in external outcomes. p and antisocial factors showed within-person reductions, while anxiety showed within-person increases over time. Despite individual variation in baseline factor scores, adolescents showed similar rates of change. CONCLUSION: The bifactor model is useful for teasing apart general and specific therapeutic changes which are conflated in standard analyses of symptom scores. CLINICAL TRIAL REGISTRATION INFORMATION: START (Systemic Therapy for At Risk Teens): A National Randomised Controlled Trial to Evaluate Multisystemic Therapy in the UK Context. http://www.isrctn.com; ISRCTN77132214.




Archive Staff Only
![]() |
View Item |